Bio-Pharma

Danbury, Conn. & Westlake Village, Calif., July 29, 2026 MannKind Corporation announced positive topline results from its Phase 1b...

New Haven, Connecticut, July 27, 2026 Yarrow Bioscience, Inc. announced the successful completion of its merger with VYNE Therapeutics...

San Diego, California, July 27, 2026 Gossamer Bio, Inc. announced a series of significant regulatory, strategic, and financial milestones...

HONG KONG, July 20, 2026 Akeso, Inc. has announced a significant milestone in its oncology pipeline with the first...

VALBY, Denmark, July 20, 2026 H. Lundbeck A/S has reached a major clinical development milestone with the last patient...

CAMBRIDGE, Mass., April 17, 2026 Marengo Therapeutics has unveiled encouraging late-breaking Phase IIa clinical results for its investigational immunotherapy...

LONDON, United Kingdom, July 20, 2026 GSK plc has announced that the European Medicines Agency (EMA) has accepted its...

TEL AVIV, Israel & OSLO, Norway, July 20, 2026 BioLineRx Ltd. and Hemispherian AS have announced that new preclinical...

Bridgewater, N.J., July 17, 2026 Amneal Pharmaceuticals announced that the U.S. Food and Drug Administration (FDA) has approved additional...

COPENHAGEN, Denmark, July 1, 2026 Evaxion A/S announced that it will present new preclinical data for its investigational cytomegalovirus...